Medicamentos genéricos: repercussões das patentes farmacêuticas na política de medicamentos

Página do item simplificado
dc.contributor.advisorNohara, Irene Patrícia
dc.contributor.advisor1Latteshttp://lattes.cnpq.br/1682399754131937por
dc.contributor.authorWandscheer, Lucelaine dos Santos Weiss
dc.creator.Latteshttp://lattes.cnpq.br/7132099303820313por
dc.date.accessioned2017-09-19T18:39:12Z
dc.date.accessioned2020-05-28T18:06:33Z
dc.date.available2020-05-28T18:06:33Z
dc.date.issued2017-08-08
dc.description.abstractThe scope and limits of patent protection for pharmaceutical products and processes have aroused much debate. Therefore, clear rules on intellectual property are fundamental, as the effects of the misuse of patents in the pharmaceutical field have repercussions on access to medicines, as evidenced by this work. Generic drugs are generally produced after the expiration of the patent term of the reference drug, and constitute an effective public policy. Promoting access to innovative medicines and other medical technologies at affordable costs to a larger portion of the population has been a public health concern. The issue is related to intellectual property rules, especially after the TRIPS Agreement, and the implementation of these rules by the Member States of the World Trade Organization (WTO). As a result of the research we identified at least two strategies used in the pharmaceutical field. The first one is called second uses, and the second data protection test. These strategies are responsible for extending patent protection for pharmaceutical products and processes, with clear detriment to the National Medicines Policy. The basis of this research is composed of themes with strong interdisciplinary links.eng
dc.formatapplication/vnd.openxmlformats-officedocument.wordprocessingml.document*
dc.identifier.citationWANDSCHEER, Lucelaine dos Santos Weiss. Medicamentos genéricos: repercussões das patentes farmacêuticas na política de medicamentos. 2017. 140 f. Dissertação (Direito Político e Econômico) - Universidade Presbiteriana Mackenzie, São Paulo.por
dc.identifier.urihttp://dspace.mackenzie.br/handle/10899/24032
dc.keywordsgeneric drugseng
dc.keywordspharmaceutical patentseng
dc.keywordsnational medicines policyeng
dc.languageporpor
dc.publisherUniversidade Presbiteriana Mackenziepor
dc.rightsAcesso Abertopor
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/
dc.subjectmedicamentos genéricospor
dc.subjectpatentes farmacêuticaspor
dc.subjectpolítica nacional de medicamentospor
dc.subject.cnpqCNPQ::CIENCIAS SOCIAIS APLICADAS::DIREITO::DIREITO PRIVADO::DIREITO COMERCIALpor
dc.subject.cnpqCNPQ::CIENCIAS SOCIAIS APLICADAS::DIREITO::DIREITO PUBLICOpor
dc.titleMedicamentos genéricos: repercussões das patentes farmacêuticas na política de medicamentospor
dc.typeDissertaçãopor
local.contributor.board1Moreira, Diogo Rais Rodrigues
local.contributor.board1Latteshttp://lattes.cnpq.br/7309547447201302por
local.contributor.board2Moro, Maitê Cecilia Fabbri
local.contributor.board2Latteshttp://lattes.cnpq.br/5471669159750359por
local.publisher.countryBrasilpor
local.publisher.departmentFaculdade de Direito (FDIR)por
local.publisher.initialsUPMpor
local.publisher.programDireito Político e Econômicopor
Arquivos
Pacote Original
Agora exibindo 1 - 1 de 1
Imagem de Miniatura
Nome:
Divulgação não autorizada pelo autor.docx
Tamanho:
11.45 KB
Formato:
Unknown data format
Descrição:
Baixar
Coleções
Direito Político e Econômico - Dissertações - Direito Higienópolis